SCHEMBL8265290

SCHEMBL8265290

Cc1cccc(CN2C(=N)NC(C)(CC(C)C)C2=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
POLB P06746 3/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 3/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
USP2 O75604 1/20 0.37
TSHR P16473 1/20 0.37
ATM Q13315 1/20 0.37
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 2/20 0.35
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM3 P20309 1/20 0.35
ELANE P08246 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7527783 0.93 LMNA (0.38) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL7526362 0.88 LMNA (0.37) MAPTLMNASMN1; SMN2
SCHEMBL8290169 0.87 LMNA (0.39) KMT2AMEN1ALDH1A1LMNAATM
SCHEMBL10305523 0.87 LMNA (0.41) KMT2AMEN1ALDH1A1LMNAATM
SCHEMBL7513320 0.87 LMNA (0.39) KMT2AMEN1LMNASMN1; SMN2IDO1
SCHEMBL7540104 0.87 LMNA (0.39) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL7527178 0.87 KMT2A (0.44) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL14104839 0.86 ELANE (0.49) KMT2AMEN1POLBALDH1A1MAPT
SCHEMBL7511298 0.86 TACR1 (0.40) ALDH1A1LMNAATMHTTELANE
SCHEMBL17715624 0.86 LMNA (0.41) KMT2AMEN1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097387-B1 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2016-05-04 EP disclosed
EP-2343069-B1 Heterocyclic aspartyl protease inhibitors MERCK SHARP & DOHME (US) 2016-03-02 EP disclosed
WO-2008103351-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2008-08-28 WO disclosed
WO-2006065277-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2006-06-22 WO disclosed
WO-2005058311-A1 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2005-06-30 WO disclosed